Altamira Therapeutics Ltd.(CYTO)

0.3000+0.00000.00%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- Altamira Therapeutics Ltd.盘中异动急速上涨5.01%
  市场透视 · 2024-12-18
  Altamira Therapeutics Ltd.盘中异动急速上涨5.01%
- Altamira Therapeutics Ltd.盘中异动快速跳水7.46%
  市场透视 · 2024-12-12
  Altamira Therapeutics Ltd.盘中异动快速跳水7.46%
- Altamira Therapeutics Ltd.盘中异动早盘快速上涨6.55%报0.490美元
  市场透视 · 2024-12-11
  Altamira Therapeutics Ltd.盘中异动早盘快速上涨6.55%报0.490美元
- Altamira Therapeutics Ltd.盘中异动快速下跌5.97%
  市场透视 · 2024-12-10
  Altamira Therapeutics Ltd.盘中异动快速下跌5.97%
- Altamira Therapeutics Ltd.盘中异动股价大涨8.21%报0.560美元
  市场透视 · 2024-12-09
  Altamira Therapeutics Ltd.盘中异动股价大涨8.21%报0.560美元
- Altamira Therapeutics Ltd.盘中异动早盘急速拉升5.26%
  市场透视 · 2024-12-07
  Altamira Therapeutics Ltd.盘中异动早盘急速拉升5.26%
- Altamira Therapeutics Ltd.盘中异动大幅拉升5.71%
  市场透视 · 2024-12-05
  Altamira Therapeutics Ltd.盘中异动大幅拉升5.71%
- Altamira Therapeutics Ltd.盘中异动股价大跌6.02%报0.450美元
  市场透视 · 2024-12-04
  Altamira Therapeutics Ltd.盘中异动股价大跌6.02%报0.450美元
- Altamira Therapeutics Ltd.盘中异动临近午盘股价大涨5.71%报0.450美元
  市场透视 · 2024-12-04
  Altamira Therapeutics Ltd.盘中异动临近午盘股价大涨5.71%报0.450美元
- Altamira Therapeutics Ltd.盘中异动股价大涨5.57%
  市场透视 · 2024-11-30
  Altamira Therapeutics Ltd.盘中异动股价大涨5.57%
- Altamira Therapeutics Ltd.盘中异动下午盘大幅拉升5.18%报0.445美元
  市场透视 · 2024-11-26
  Altamira Therapeutics Ltd.盘中异动下午盘大幅拉升5.18%报0.445美元
- Altamira Therapeutics Ltd.盘中异动早盘大幅跳水5.12%报0.415美元
  市场透视 · 2024-11-22
  Altamira Therapeutics Ltd.盘中异动早盘大幅跳水5.12%报0.415美元
- Altamira Therapeutics Ltd.盘中异动早盘急速上涨6.85%报0.440美元
  市场透视 · 2024-11-20
  Altamira Therapeutics Ltd.盘中异动早盘急速上涨6.85%报0.440美元
- Altamira Therapeutics Ltd.盘中异动早盘股价大跌6.89%报0.402美元
  市场透视 · 2024-11-19
  Altamira Therapeutics Ltd.盘中异动早盘股价大跌6.89%报0.402美元
- Altamira Therapeutics Ltd.盘中异动下午盘急速跳水5.12%报0.432美元
  市场透视 · 2024-11-19
  Altamira Therapeutics Ltd.盘中异动下午盘急速跳水5.12%报0.432美元
- Altamira Therapeutics Ltd.盘中异动早盘大幅上涨7.00%报0.492美元
  市场透视 · 2024-11-13
  Altamira Therapeutics Ltd.盘中异动早盘大幅上涨7.00%报0.492美元
- Altamira Therapeutics Ltd.盘中异动早盘急速下跌5.25%
  市场透视 · 2024-11-11
  Altamira Therapeutics Ltd.盘中异动早盘急速下跌5.25%
- Altamira Therapeutics Ltd.盘中异动股价大跌5.77%报0.490美元
  市场透视 · 2024-11-07
  Altamira Therapeutics Ltd.盘中异动股价大跌5.77%报0.490美元
- Altamira Therapeutics Ltd.盘中异动急速下跌6.64%
  市场透视 · 2024-11-05
  Altamira Therapeutics Ltd.盘中异动急速下跌6.64%
- Altamira Therapeutics Ltd.盘中异动股价大涨6.11%报0.510美元
  市场透视 · 2024-10-31
  Altamira Therapeutics Ltd.盘中异动股价大涨6.11%报0.510美元
公司概况
公司名称
Altamira Therapeutics Ltd.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.altamiratherapeutics.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Altamira Therapeutics Ltd.成立于1998年。该公司的目标是成为一家领先的生物医药公司，专注于开发和商业化RNA递送技术。该公司认为，使用RNA疗法,无论是siRNA、mRNA还是其他类型来控制疾病相关基因的表达，前景广阔。通过利用小分子和蛋白质在其他方面“无法药效”的靶点，有望开辟治疗疑难杂症的RNA疗法的全新途径。
- 2024-11-14
  超过5%披露
  Form SC 13G - Statement of Beneficial Ownership by Certain Investors
  Form SC 13G - Statement of Beneficial Ownership by Certain Investors
- 2024-09-17
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-09-17
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-09-16
  [修订]招股说明书
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2024-09-16
  [修订]招股说明书
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2024-08-22
  招股说明书
  Form F-1 - Registration statement for certain foreign private issuers
  Form F-1 - Registration statement for certain foreign private issuers
- 2024-07-01
  [修订]年度报告
  Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
  Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
- 2024-04-22
  [修订]年度报告
  Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
  Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
- 2024-04-17
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-04-10
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 2024-04-10
  招股说明书
  Form F-1 - Registration statement for certain foreign private issuers
  Form F-1 - Registration statement for certain foreign private issuers
- 2024-04-10
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2024-03-13
  超过5%披露
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
- 2024-01-17
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2023-07-05
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence

分时
5日
日
周
月

数据加载中...

最高

0.3000

今开

0.3000

量比

0.00

最低

0.3000

昨收

0.3000

换手率

0.00%

Altamira Therapeutics Ltd.(CYTO)

公司概况

热议股票